Literature DB >> 29236566

Genome profile in a extremely rare case of pulmonary sclerosing pneumocytoma presenting with diffusely-scattered nodules in the right lung.

Xiangshan Fan1, Ling Lin2, Jianjun Wang1, Yu Wang2, Anning Feng1, Ling Nie1, Hongyan Wu1, Fanqing Meng1, Haodong Xu3.   

Abstract

BACKGROUND: Pulmonary sclerosing pneumocytoma (PSP) typically presents solitary and peripheral mass, while only rarely cases display unusual multiple lesions. We reported a extremely rare case of PSP with diffusely-scattered nodules in the right lung. CASE
PRESENTATION: Diffusely round-shaped nodular shadows in the right lung were found by CT scan in a 31-year-old Chinese woman. The patient undergone the right pneumnectomy. Grossly, numerous small nodules, up to 2.5 cm in greatest dimension were identified in the upper, middle and lower lobes of the right lung. Histologically, the tumor presented the typical features of PSP, with a variable proportion of solid, sclerotic and papillary patterns. Immunohistochemical staining further revealed that cuboidal surface epithelial cells were positive for TTF-1, EMA, AE1/3 and vimentin (partially), and round or polygonal cells expressed TTF-1, vimentin, EMA (weakly), synaptophysin (partially), progesterone receptor (partially), and estrogen receptor (scatteredly). The patient has been followed up for 83 months after surgery by annual chest CT and no new lesions are detected in her left lung and other organs. The whole-exome sequencing identified 15 somatic mutations genes (MEGF6, DNAH5, AKT1, GPRIN2, PIK3AP1, FBXO40, HERC1, VPS16, MORN1, ZNF474, CTNNB1, ZNF251, TSC1, ATM, KDR). Pathway analysis showed possible pathways like the components of CTNNB1, AKT1, and TSC1 mutations in the PI3K/AKT signalings and AKT1, KDR and ATM in VEGF signaling pathway and AKT1 activation seemed closely related with these pathways.
CONCLUSION: According to our and previous data, PSP with diffuse or multiple lesions is very rare, and the patients are most commonly seen in women in Asian countries. The misdiagnosis rate by clinical and intraoperative frozen-section assessment is high because of the multiple nodules in the lung and its confusing histological features. Long time follow up indicates surgical resection should not be considered as the preferred strategy for treating multiple PSP in the intralobar sites. AKT1 activation may contribute to the development of PSP while the pathogenesis of diffuse or multiple PSP still needs to be further analyzed.

Entities:  

Keywords:  diffuse pulmonary nodules; genome profile; sclerosing pneumocytoma

Mesh:

Substances:

Year:  2017        PMID: 29236566      PMCID: PMC5790398          DOI: 10.1080/15384047.2017.1360443

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  29 in total

1.  Pulmonary sclerosing hemangioma with lymph node metastases.

Authors:  N G Chan; D E Melega; R I Inculet; J G Shepherd
Journal:  Can Respir J       Date:  2003-10       Impact factor: 2.409

2.  Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung.

Authors:  Seung-Hyun Jung; Min Sung Kim; Sung-Hak Lee; Hyun-Chun Park; Hyun Joo Choi; Leeso Maeng; Ki Ouk Min; Jeana Kim; Tae In Park; Ok Ran Shin; Tae-Jung Kim; Haidong Xu; Kyo Young Lee; Tae-Min Kim; Sang Yong Song; Charles Lee; Yeun-Jun Chung; Sug Hyung Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

3.  [A case of multiple sclerosing hemangiomas of both lungs].

Authors:  Kazuhisa Ito; Takuro Sakagami; Tetsuya Abe; Nanako Tsutsui; Haruhiko Nakajima; Michihiko Haraguchi
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2006-11

4.  Clinicopathological analysis of pulmonary sclerosing hemangioma.

Authors:  Akira Iyoda; Kenzo Hiroshima; Mitsutoshi Shiba; Yukiko Haga; Yasumitsu Moriya; Yasuo Sekine; Kiyoshi Shibuya; Toshihiko Iizasa; Takehiko Fujisawa
Journal:  Ann Thorac Surg       Date:  2004-12       Impact factor: 4.330

5.  [Surgery treatment for pulmonary sclerosing hemangioma].

Authors:  Dong Xie; Ge-ning Jiang; Xiao-feng Chen; Zhi-fei Xu; Xiao-fang You; Jia-an Ding
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2012-02-01

Review 6.  [A case of multiple sclerosing hemangiomas of the lung and a review of the literature in Japan].

Authors:  K Maezato; S Hitomi; M Kuwabara
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1989-02

7.  Multiple sclerosing hemangiomas of the lung.

Authors:  M Noguchi; T Kodama; S Morinaga; Y Shimosato; T Saito; E Tsuboi
Journal:  Am J Surg Pathol       Date:  1986-06       Impact factor: 6.394

8.  Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers.

Authors:  Chaitali Parikh; Vasantharajan Janakiraman; Wen-I Wu; Catherine K Foo; Noelyn M Kljavin; Subhra Chaudhuri; Eric Stawiski; Brian Lee; Jie Lin; Hong Li; Maria N Lorenzo; Wenlin Yuan; Joseph Guillory; Marlena Jackson; Jesus Rondon; Yvonne Franke; Krista K Bowman; Meredith Sagolla; Jeremy Stinson; Thomas D Wu; Jiansheng Wu; David Stokoe; Howard M Stern; Barbara J Brandhuber; Kui Lin; Nicholas J Skelton; Somasekar Seshagiri
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-07       Impact factor: 11.205

9.  Pulmonary sclerosing hemangioma: report of two cases.

Authors:  Chuang He; Hongyang Fang; Yun Liu; Xuequan Huang; Wei Zhen; Li Ren
Journal:  World J Surg Oncol       Date:  2012-09-03       Impact factor: 2.754

10.  Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.

Authors:  M S Kim; E G Jeong; N J Yoo; S H Lee
Journal:  Br J Cancer       Date:  2008-04-08       Impact factor: 7.640

View more
  5 in total

1.  Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report.

Authors:  Takashi Sakai; Tomohiro Miyoshi; Shigeki Umemura; Jun Suzuki; Shoko Nakasone; Satoshi Okada; Kenta Tane; Keiju Aokage; Koichi Goto; Noriko Motoi; Genichiro Ishii; Masahiro Tsuboi
Journal:  Oxf Med Case Reports       Date:  2019-07-01

Review 2.  HERCing: Structural and Functional Relevance of the Large HERC Ubiquitin Ligases.

Authors:  Jesús García-Cano; Arturo Martinez-Martinez; Joan Sala-Gaston; Leonardo Pedrazza; Jose Luis Rosa
Journal:  Front Physiol       Date:  2019-08-07       Impact factor: 4.566

3.  ZNF251 promotes the progression of lung cancer by activating ERK signaling.

Authors:  Chenxi Zhong; Chunji Chen; Feng Yao; Wentao Fang
Journal:  Cancer Sci       Date:  2020-07-15       Impact factor: 6.716

4.  [Analysis of Clinical Characteristics of 35 Cases 
of Pulmonary Sclerosing Pneumocytoma].

Authors:  Xiaojing Liu; Zhihao Huang; Jianyong Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-12-20

5.  Clinical Characteristics of Malignant Pulmonary Sclerosing Pneumocytoma Based on a Study of 46 Cases Worldwide.

Authors:  Weidong Zhang; Dong Cui; Yaqian Liu; Kefeng Shi; Xia Gao; Rulin Qian
Journal:  Cancer Manag Res       Date:  2022-08-13       Impact factor: 3.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.